Drug Shortage Report for VOLUVEN
| Report ID | 139230 |
| Drug Identification Number | 02278057 |
| Brand name | VOLUVEN |
| Common or Proper name | Voluven® (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection) 250 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROXYETHYL STARCH 130/0.4 |
| Strength(s) | 6% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 250 mL |
| ATC code | B05AA |
| ATC description | BLOOD AND RELATED PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-05-12 |
| Actual start date | 2021-05-12 |
| Estimated end date | 2021-09-06 |
| Actual end date | 2021-08-25 |
| Shortage status | Resolved |
| Updated date | 2021-08-26 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2021-08-26 | English | Compare |
| v8 | 2021-08-25 | French | Compare |
| v7 | 2021-08-25 | English | Compare |
| v6 | 2021-06-23 | French | Compare |
| v5 | 2021-06-23 | English | Compare |
| v4 | 2021-06-23 | English | Compare |
| v3 | 2021-05-13 | English | Compare |
| v2 | 2021-05-12 | French | Compare |
| v1 | 2021-05-12 | English | Compare |
Showing 1 to 9 of 9